Autonomic neural regulation of the immune system: Implications for hypertension and cardiovascular disease

Hypertension

Volumn 59, Issue 4, 2012, Pages 755-762

  Abboud, François M ^a,b   Harwani, Sailesh C ^a,b   Chapleau, Mark W ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b Department of Internal Medicine ^*  (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 16; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NORADRENALIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CAROTID SINUS NERVE; CHRONIC DISEASE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; GENE EXPRESSION; HEART FAILURE; HEART INFARCTION; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; IMMUNE DYSREGULATION; IMMUNOREGULATION; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMPATHETIC NERVE; T LYMPHOCYTE; UPREGULATION; VAGUS NERVE STIMULATION;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; IMMUNE SYSTEM; T-LYMPHOCYTES;

EID: 84858698332     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.186833     Document Type: Review

References (60)

1. Abboud FM. The sympathetic system in hypertension: state-of-the-art review. Hypertension. 1982;4:208-225.
2. Esler M. The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Exp Physiol. 2011;96:611-622.
3. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335-346.
4. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724-728. (Pubitemid 29501288)
5. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96: 1897-1904.
6. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823. (Pubitemid 14035089)
7. Korner P, Bobik A, Oddie C, Friberg P. Sympathoadrenal system is critical for structural changes in genetic hypertension. Hypertension. 1993;22:243-252. (Pubitemid 23234072)
8. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ, for the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478-484. (Pubitemid 28070094)
9. Mortara A, La Rovere MT, Pinna GD, Prpa A, Maestri R, Febo O, Pozzoli M, Opasich C, Tavazzi L. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation. 1997;96:3450-3458. (Pubitemid 27513419)
10. Robinson TG, Dawson SL, Eames PJ, Panerai RB, Potter JF. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke. 2003;34:705-712.
11. Abboud FM. The Walter B. Cannon Memorial Award Lecture, 2009. Physiology in perspective: the wisdom of the body-in search of autonomic balance: the good, the bad, and the ugly. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1449-R1467.
12. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA. 2006;103:17985-17990. (Pubitemid 44852272)
13. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res. 2004; 95:210-216. (Pubitemid 38988688)
14. Fukuda Y, Sato A, Trzebski A. Carotid chemoreceptor discharge responses to hypoxia and hypercapnia in normotensive and spontaneously hypertensive rats. J Auton Nerv Syst. 1987;19:1-11. (Pubitemid 17059985)
15. Tan ZY, Lu Y, Whiteis CA, Simms AE, Paton JF, Chapleau MW, Abboud FM. Chemoreceptor hypersensitivity, sympathetic excitation, and overexpression of ASIC and TASK channels before the onset of hypertension in SHR. Circ Res. 2010;106:536-545.
16. Lawrence IG, Weston PJ, Bennett MA, McNally PG, Burden AC, Thurston H. Is impaired baroreflex sensitivity a predictor or cause of sudden death in insulin-dependent diabetes mellitus? Diabet Med.1997; 14:82-85. (Pubitemid 27019928)
17. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458-462. (Pubitemid 30367422)
18. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ. Nicotinic acetylcholine receptor 7 subunit is an essential regulator of inflammation. Nature. 2003;421:384-388. (Pubitemid 36157937)
19. Tracey KJ. The inflammatory reflex. Nature. 2002;420:853-859. (Pubitemid 36019638)
20. Zucker IH, Hackley JF, Cornish KG, Hiser BA, Anderson NR, Kieval R, Irwin ED, Serdar DJ, Peuler JD, Rossing MA. Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension. 2007;50:904-910. (Pubitemid 350287533)
21. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation. 2004;109:120-124. (Pubitemid 38056032)
22. Uemura K, Li M, Tsutsumi T, Yamazaki T, Kawada T, Kamiya A, Inagaki M, Sunagawa K, Sugimachi M. Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemiareperfusion injury in rabbit. Am J Physiol Heart Circ Physiol. 2007;293: H2254-H2261. (Pubitemid 47605869)
23. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of theβ-adrenergic pathway. Circulation. 1998;98:1329-1334. (Pubitemid 28443398)
24. Lohmeier T, EIliescu R. Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy. Hypertension. 2011;57:880-886.
25. Cabassi A, Vinci S, Calzolari M, Bruschi G, Borghetti A. Regional sympathetic activity in pre-hypertensive phase of spontaneously hypertensive rats. Life Sci. 1998;62:1111-1118. (Pubitemid 28085432)
26. Lu Y, Whiteis CA, Chapleau MW, Abboud FM. Deceased mRNA expression of ASIC2a in nodose sensory ganglia is associated with development of hypertension in SHR [abstract]. FASEB J. 2007;21: A1405.
27. Doumas M, Guo D, Papademetriou V. Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions. Expert Opin Ther Targets. 2009;13:413-425.
28. Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, Peters T, Sweep FC, Haller H, Pichlmaier AM, Luft FC, Jordan J. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension. 2010;55: 619-626.
29. Wustmann K, Kucera JP, Scheffers I, Mohaupt M, Kroon AA, de Leeuw PW, Schmidli J, Allemann Y, Delacretaz E. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension. 2009;54: 530-536.
30. Hauptman PJ, Mann DL. The vagus nerve and autonomic imbalance in heart failure: past, present, and future. Heart Fail Rev. 2011;16: 97-99.
31. Sabbah HN. Electrical vagus nerve stimulation for the treatment of chronic heart failure. Cleve Clin J Med. 2011;78(suppl 1) S24-S29.
32. Sabbah HN, Ilsar I, Zaretsky A, Rastogi S, Wang M, Gupta RC. Vagus nerve stimulation in experimental heart failure. Heart Fail Rev. 2011;16: 171-178.
33. Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J. Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol. 2011;27:174-182.
34. Svendsen UG. Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice. Acta Pathol Microbiol Scand A. 1976;84:523-528.
35. Ba D, Takeichi N, Kodama T, Kobayashi H. Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J Immunol. 1982;128:1211-1216. (Pubitemid 12188439)
36. Pascual VH, Oparil S, Eldridge JH, Jin H, Bost KL, Pascual DW. Spontaneously hypertensive rat: lymphoid depression is age dependent and mediated via a mononuclear cell subpopulation. Am J Physiol. 1992; 262:R1-R7.
37. Khraibi AA. Association between disturbances in the immune system and hypertension. Am J Hypertens. 1991;4:635-641.
38. Huang XR, Chung AC, Yang F, Yue W, Deng C, Lau CP, Tse HF, Lan HY. Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension. 2010;55: 1165-1171.
39. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399-403. (Pubitemid 34225673)
40. Melendez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension. 2010;56:225-231.
41. Brands MW, Banes-Berceli AK, Inscho EW, Al-Azawi H, Allen AJ, Labazi H. Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation. Hypertension. 2010;56:879-884.
42. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204:2449-2460. (Pubitemid 47529329)
43. Harwani SC, Chapleau MW, Legge K, Ballas Z, Abboud FM. Autonomic dysregulation of innate immunity in genetic hypertension [abstract]. Hypertension. 2011;58:e50.
44. Harrison DG, Vinh A, Lob H, Madhur MS. Role of the adaptive immune system in hypertension. Curr Opin Pharmacol. 2010;10:203-207.
45. Zubcevic J, Waki H, Raizada MK, Paton JF. Autonomic-immunevascular interaction: an emerging concept for neurogenic hypertension. Hypertension. 2011;57:1026-1033.
46. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007;21: 736-745. (Pubitemid 47002215)
47. Schauenstein K, Felsner P, Rinner I, Liebmann PM, Stevenson JR, Westermann J, Haas HS, Cohen RL, Chambers DA. In vivo immunomodulation by peripheral adrenergic and cholinergic agonists/antagonists in rat and mouse models. Ann N Y Acad Sci. 2000;917: 618-627.
48. Ganta CK, Lu N, Helwig BG, Blecha F, Ganta RR, Zheng L, Ross CR, Musch TI, Fels RJ, Kenney MJ. Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system. Am J Physiol Heart Circ Physiol. 2005;289:H1683-H1691. (Pubitemid 41369013)
49. O'Mahony C, van der Kleij H, Bienenstock J, Shanahan F, O'Mahony L. Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol. 2009;297: R1118-R1126.
50. Karimi K, Bienenstock J, Wang L, Forsythe P. The vagus nerve modulates CD4+T cell activity. Brain Behav Immun. 2010;24:316-323.
51. Skok M, Grailhe R, Changeux JP. Nicotinic receptors regulate B lymphocyte activation and immune response. Eur J Pharmacol. 2005;517: 246-251. (Pubitemid 40977902)
52. Rosas-Ballina M, Olofsson PS, Ochani M, Valdes-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan S, Mak TW, Tracey KJ. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011;334:98-101.
53. Zhang Y, Popovic ZB, Bibevski S, Fakhry I, Sica DA, Van Wagoner DR, Mazgalev TN. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail. 2009;2:692-699.
54. Trakhtenberg EF, Goldberg JL. Immunology: neuroimmune communication. Science. 2011;334:47-48.
55. Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, Sriramula S, Francis J, Sumners C, Raizada MK. Brain microglial cytokines in neurogenic hypertension. Hypertension. 2010;56:297-303.
56. Waki H, Liu B, Miyake M, Katahira K, Murphy D, Kasparov S, Paton JF. Junctional adhesion molecule-1 is upregulated in spontaneously hypertensive rats: evidence for a prohypertensive role within the brain stem. Hypertension. 2007;49:1321-1327. (Pubitemid 46809375)
57. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011;30:16-34.
58. Bianchi ME. DAMPs PAM. Ps and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81:1-5. (Pubitemid 46028489)
59. Wang Y, Zhang F, Yang W, Xue S. Nicotine induces pro-inflammatory response in aortic vascular smooth muscle cells through a NFkappaB/osteopontin amplification loop-dependent pathway. Inflammation. Epub ahead of print April 15, 2011.
60. Thabet S, Wu J, Chen W, Marvar P, Gongora M, Madhur M, Binder Y, Weyand H, Harrison DG. The role of CD8+T Cells, IP-10, and MMP12 in hypertension [abstract]. Hypertension. 2011;58:e49.